HLA-DRB1∗07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population

Transfusion

Volumn 54, Issue 10, 2014, Pages 2468-2476

  Baleotti, Wilson ^a   Ruiz, Marcelo Ortega ^b   Fabron, Antonio ^b   Castilho, Lilian ^c   Giuliatti, Silvana ^d   Donadi, Eduardo Antonio ^d  

^a FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^b Laboratõrio Diagnõsticos Do Brasil   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB1 07 01 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; UNCLASSIFIED DRUG; ALLOANTIGEN; HLA-DRB1*07 ANTIGEN;

ADULT; AGED; ALLELE; ALLOIMMUNIZATION; AMINO ACID SEQUENCE; ARTICLE; BLOOD GROUP SYSTEM; BRAZILIAN; COMPUTER MODEL; CONTROLLED STUDY; COOMBS TEST; DESENSITIZATION; DIEGO BLOOD GROUP SYSTEM; FEMALE; GENOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; ADOLESCENT; AMINO ACID SUBSTITUTION; BLOOD; BRAZIL; CHILD; EPIDEMIOLOGY; ERYTHROCYTE; GENETICS; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; AMINO ACID SUBSTITUTION; BRAZIL; CHILD; ERYTHROCYTES; FEMALE; HLA-DRB1 CHAINS; HUMANS; ISOANTIGENS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84908109688     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12652     Document Type: Article

References (31)

1. Jay D, Cantley L,. Structural aspects of the red cell anion exchange protein. Annu Rev Biochem 1986; 55: 511-538.
2. Lux SE, John KM, Kopito RR, et al. Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1). Proc Natl Acad Sci U S A 1989; 86: 9089-9093.
3. Tanner MJ, Martin PG, High S,. The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence. Biochem J 1988; 256: 703-712.
4. Tanner MJ,. The structure and function of band 3 (AE1): recent developments (review). Mol Membr Biol 1997; 14: 155-165.
5. Bruce LJ, Ring SM, Anstee DJ, et al. Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions. Blood 1995; 85: 541-547.
6. Bruce LJ, Zelinski T, Ridgwell K, et al. The low-incidence blood group antigen, Wda, is associated with the substitution Val557 - >Met in human erythrocyte band 3 (AE1). Vox Sang 1996; 71: 118-120.
7. Jarolim P, Murray JL, Rubin HL, et al. A Thr552 - >Ile substitution in erythroid band 3 gives rise to the Warrior blood group antigen. Transfusion 1997; 37: 398-405.
8. Jarolim P, Murray JL, Rubin HL, et al. Blood group antigens Rb(a), Tr(a), and Wd(a) are located in the third ectoplasmic loop of erythroid band 3. Transfusion 1997; 37: 607-615.
9. Jarolim P, Rubin HL, Zakova D, et al. Characterization of seven low incidence blood group antigens carried by erythrocyte band 3 protein. Blood 1998; 92: 4836-4843.
10. Daniels GL, Anstee DJ, Cartron JP, et al. International Society of Blood Transfusion Working Party on terminology for red cell surface antigens. Vox Sang 2001; 80: 193-197.
11. Storry JR, Castilho L, Daniels G, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011; 101: 77-82.
12. Baleotti W, Jr, Rios M, Reid ME, et al. A novel DI∗A allele without the Band 3-Memphis mutation in Amazonian Indians. Vox Sang 2003; 84: 326-330.
13. Layrisse M, Arends T,. The Diego system; steps in the investigation of a new blood group system; further studies. Blood 1957; 12: 115-122.
14. Bruce LJ, Anstee DJ, Spring FA, et al. Band 3 Memphis variant II. Altered stilbene disulfonate binding and the Diego (Dia) blood group antigen are associated with the human erythrocyte band 3 mutation Pro854 - >Leu. J Biol Chem 1994; 269: 16155-16158.
15. Treml A, King KE,. Red blood cell alloimmunization: lessons from sickle cell disease. Transfusion 2013; 53: 692-695.
16. Shariatmadar S, Pyrsopoulos NT, Vincek V, et al. Alloimmunization to red cell antigens in liver and multivisceral transplant patients. Transplantation 2007; 84: 527-531.
17. Moise KJ,. Red blood cell alloimmunization in pregnancy. Semin Hematol 2005; 42: 169-178.
18. Nurse GT, Jenkins T,. Genetically determined hazards of blood transfusion within and between races. S Afr Med J 1973; 47: 56-61.
19. Tormey CA, Stack G,. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009; 114: 4279-4282.
20. Giblett ER,. A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961; 1: 233-238.
21. Rammensee HG,. Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 1995; 7: 85-96.
22. Menconi F, Osman R, Monti MC, et al. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A 2010; 107: 16899-16903.
23. Singh A, Sharma P, Kar HK, et al. HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo. J Invest Dermatol 2012; 132: 124-134.
24. Picard C, Frassati C, Basire A, et al. Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a Southern European population. Transfusion 2009; 49: 2412-2417.
25. Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006; 46: 1328-1333.
26. Zhang L, Chen Y, Wong HS, et al. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules. Plos One 2012; 7: e30483.
27. Green A,. The epidemiologic approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiologic and preventive fraction. Tissue Antigens 1982; 19: 259-268.
28. Reviron D, Dettori I, Ferrera V, et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion 2005; 45: 956-959.
29. Arnold PY, La Gruta NL, Miller T, et al. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues. J Immunol 2002; 169: 739-749.
30. Vignali DA, Strominger JL,. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J Exp Med 1994; 179: 1945-1956.
31. Chiaroni J, Dettori I, Ferrera V, et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006; 132: 374-378.